QUE Oncology launches Phase II trials in the United States
Posted:
2019-04-02 in Press Releases
MRCF launches Perth-based biotech developing new treatment for Cystic Fibrosis
Posted:
2019-03-15 in Press Releases
Aravax reveals positive Phase I trial results at world-leading allergy conference
Posted:
2019-02-25 in Press Releases
Australian Phase II trial commences for potential world-first treatment of viral conjunctivitis
Posted:
2019-01-31 in Press Releases
Perth tech joint-winner in global finals for international start-up competition
Posted:
2018-12-13 in Press Releases
Perth tech takes out Australian start-up competition to join international finals
Posted:
2018-12-03 in Press Releases
The WILD Program launches within the Victorian STEM sector, with first intake of 20 women
Posted:
2018-11-21 in Press Releases
QUE Oncology launches Phase II trials
Posted:
2018-10-02 in Press Releases
PolyActiva commences first Phase I clinical trial with potential to improve lives of millions
Posted:
2018-08-31 in Press Releases
Paragen Bio launches in northern Queensland with $6 million investment
Posted:
2018-08-14 in Press Releases